Skip to main content
Home
Member Login
Join Our Contact Registry
RDCRN Alumni badge

Header Social Media

  • Our Research
    • Diseases Studied
    • Research Studies
    • Clinical Sites
    • Research Publications
    • Prior Research
  • Patients and Families
    • Patient Advocacy Groups
    • Resources for Patients and Families
    • Glossary
  • Researchers and Clinicians
    • Clinical Ambassadors
    • Funding Opportunities
    • Lectures
  • Early Stage Investigators
    • Funding Opportunities
    • Pilot and Feasibility Grants
    • Scholar Awards
    • Meet Our Early Stage Investigators
  • News and Events
    • Latest News
  • About Us
    • Our Consortium
    • Meet Our Team
    • Goals, Mission & Vision
    • Frequently Asked Questions
    • Contact Us
A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

NIH Announces Funding to Establish and Strengthen Rare Disease Research Groups

The National Institutes of Health (NIH) has awarded approximately $26 million in grants in the fiscal year 2025 to begin the fifth cycle of funding for the Rare Diseases Clinical Research Network (RDCRN).

Read More
Honeycomb-style infographic showing the structure of the Rare Diseases Clinical Research Network with consortia names

RDCRN Research Roundup: July 2022

July 6, 2022

Read More
Rare Diseases Clinical Research Network logo with text: Research Roundup, #RDCRN

FCDGC Announces 2021 Pilot Grant Award Recipients

April 19, 2021

Read More
FCGDC2021PilotGrantWinners

Rare Disease Research Challenges, Opportunities Due to COVID-19 Featured in New Article

May 4, 2021

Read More
rare-disease-neuro-special-report

New Genetic Marker Identified for Congenital Disorders of Glycosylation

July 8, 2021

Read More
The Frontiers in Congenital Disorders of Glycosylation (FCDGC) logo appears over a gray graphic of molecules

RDCRN Research Roundup: December 2021

December 9, 2021

Read More
Research Roundup. #RareDiseasesSpotlight. Rare Diseases Clinical Research Network

FCDGC Announces 2021 Career Enhancement Fellows

October 20, 2021

Read More
FCDGC-career-enhancement-fellows

FCDGC Natural History Study Reveals Liver Implications for Patients with CDG

January 27, 2021

Read More
A screenshot of the NH Liver Study Team participating in a video conference

Researchers Establish New Consensus Guidelines for Congenital Disorders of Glycosylation

December 7, 2020

Read More
Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) logo
  • Load More
Join Our Email List

Footer menu

  • Web Policies
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). FCDGC received funding under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the FCDGC administrative coordinating center at Icahn School of Medicine at Mount Sinai, New York, and does not necessarily represent the official views of the NIH.